
Keywords: βAla; βalanine; Bantag-1; selective BRS-3 peptide antagonist; Bn; bombesin; BnR; bombesin receptor; BRS-3(BB3); bombesin receptor subtype 3; COOH terminus; carboxyl terminus; CCK; cholecystokinin; CNS; central nervous system; Cpa; chlorophenylalanine; D